Re:
|
Ocuphire Pharma, Inc.
|
||
Registration Statement on Form S-3
|
|||
File No. 333-252715
|
|||
Acceleration Request
|
|||
Requested Date:
|
February 12, 2021
|
||
Requested Time:
|
4:30 P.M. Eastern Time
|
Sincerely,
|
|
Ocuphire Pharma, Inc.
|
|
/s/ Mina Sooch
|
|
Mina Sooch
|
|
Chief Executive Officer
|
cc:
|
Phillip Torrence, Honigman LLP
|
Emily Johns, Honigman LLP
|